JACOBS LEVY EQUITY MANAGEMENT, INC - UNITY BIOTECHNOLOGY INC ownership

UNITY BIOTECHNOLOGY INC's ticker is UBX and the CUSIP is 91381U101. A total of 82 filers reported holding UNITY BIOTECHNOLOGY INC in Q3 2020. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of UNITY BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2021$1,625,000
-53.9%
541,520
-28.7%
0.01%
-54.2%
Q2 2021$3,526,000
+2.1%
759,918
+32.1%
0.02%
-11.1%
Q1 2021$3,453,000
+66.8%
575,443
+45.7%
0.03%
+50.0%
Q4 2020$2,070,000
+421.4%
394,957
+243.8%
0.02%
+350.0%
Q3 2020$397,000
-81.7%
114,878
-54.1%
0.00%
-83.3%
Q2 2020$2,172,000
+18.9%
250,251
-20.6%
0.02%
+4.3%
Q1 2020$1,827,000
-24.9%
315,047
-6.7%
0.02%
-4.2%
Q4 2019$2,433,000
+768.9%
337,496
+878.2%
0.02%
+500.0%
Q1 2019$280,00034,5000.00%
Other shareholders
UNITY BIOTECHNOLOGY INC shareholders Q3 2020
NameSharesValueWeighting ↓
Founders Fund V Management, LLC 491,751$275,0002.22%
GSA CAPITAL PARTNERS LLP 639,937$361,0000.05%
PURA VIDA INVESTMENTS, LLC 359,089$202,0000.01%
Caption Management, LLC 725,000$409,0000.01%
Forefront Analytics, LLC 20,377$11,0000.01%
Johnson Midwest Financial, LLC 6,100$3,0000.00%
Virtu Financial LLC 62,640$35,0000.00%
Caption Management, LLC 225,000$127,0000.00%
SeaCrest Wealth Management, LLC 25,000$14,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 191,450$108,0000.00%
View complete list of UNITY BIOTECHNOLOGY INC shareholders